Amy Hauck Newman is an American medicinal chemist who is the scientific director of the intramural research program at the National Institute on Drug Abuse.

[1] Newman received her Ph.D. in medicinal chemistry from the Medical College of Virginia under the mentorship of Richard A.

[2] For her postdoctoral studies, she joined the laboratory of Kenner C. Rice at the National Institutes of Health (NIH).

[2] Her laboratory explores the creation of amide-based compounds that interact with glutamate receptors, which are also implicated in substance abuse.

[2] In 2018, she was honored as a “Remarkable Woman in Medicinal Chemistry” at the 255th American Chemical Society National Meeting.